Skip to main content
Powered by ShareScore

Find research datasets worth reusing

Search datasets from major research repositories and use ShareScore to quickly assess how well each record supports discovery, access, and reuse.

22

datasets available to search

ShareScore release 0.9.0

Reset

Dataset results

22 results for “mvp”

Learn how ShareScore rates datasets ↗
zenodo40/100

Moving vessel profiler (MVP) transects from PolarFront 2022-05 cruise

<p><strong>MVP transects 2022-05</strong></p> <p><span>The Moving Vessel Profiler (MVP) was deployed to collect data with high-spatial resolution along transects aiming to cross the front. Instruments contained in the profiling unit ("fish") of the winch were a CTD (AML &micro;CTD), a fluorescence sensor (WETLABS) and a laser optical plankton counter (LOPC). </span></p> <p><span>Together the instruments yield data on the physical environment, phytoplankton, zooplankton and other particle distributions.</span></p> <p><span>Weather conditions during the cruise allowed sampling along two transects (S1 and parts of S2). However, S1 did not cross the polar front due to too thick ice cover in the North. The south (waves to high) and north (ice) of transect S2 were sampled by a different platform, data elsewhere, together resulting in a complete transect crossing the front.</span></p> <p><span>Coverage</span></p> <p><span>Transect S1 start: 75 N, 29 30' E, 20 May at 06:57 UTC<br></span><span>Transect S1 end: 75 55' N, 29 54' E, 20 May at 16:16 UTC</span></p> <p><span>Transect S2 start: 75 24' N, 29 E, 23 May at 16:03 UTC<br></span><span>Transect S2 end: 76 43' N, 29 30' E, 24 May at 03:43 UTC</span></p> <p>S1: 2022-05-20T06:57Z/2022-05-20T06:57Z<br>S2: 2022-05-23T16:16Z/2022-05-24T03:43Z&nbsp;</p>

opencc-zeroMay 2022View details →
zenodo36/100

Moving vessel profiler (MVP) transect from PolarFront 2023-08 cruise

<p><span>The Moving Vessel Profiler (MVP) was deployed to collect data with high-spatial resolution along our </span><span>transect crossing the front. Instruments contained in the profiling unit ("fish") of the winch were a CTD </span><span>(AML &micro;CTD), a fluorescence sensor (WETLABS) and a laser optical plankton counter (LOPC).&nbsp;</span></p> <p><span>Together the instruments yield data on the physical environment, phytoplankton, zooplankton and other </span><span>particle distributions</span></p> <p><span>During the entire deployment of the MVP, weather conditions were optimal with very low wind speeds </span><span>and calm sea. Apart from one stop at the surface due to a fishing vessel in our transect (20 min stop), </span><span>no sampling issues whatsoever were experienced. A few breaks along the transect were taken to collect </span><span>water samples and to set out the Sailbuoy and Seaglider.</span></p> <p><span>Transect start: 75N, 29 30' E, 17 August at 02:13 UTC</span></p> <p><span>Transect end: 78N, 29 30' E, 18 August at 11:09 UTC</span></p> <p><span>In total the transect was 333 km long and 382 profiles to 25 m above bottom were collected, resulting </span><span>in a spatial resolution of, on average, 1 profile every 870 m.</span></p>

opencc-zeroAug 2023View details →
ClinicalTrials.gov36/100

PreFER Managed Ventricular Pacing (MVP) For Elective Replacement

ClinicalTrials.gov study NCT00293241. IPD Sharing: Not stated. Countries: 1. Publications: 1.

restrictedIPD-UNDECIDEDFeb 2026View details →
ClinicalTrials.gov36/100

Managed Ventricular Pacing ("MVP") Trial

ClinicalTrials.gov study NCT00281099. IPD Sharing: Not stated. Countries: 12. Publications: 1.

restrictedIPD-UNDECIDEDFeb 2026View details →
zenodo32/100

Shotgun MVP: Reducing risk in highly unpredictable ML products

<p>Machine learning products do not fit neatly into the agile methodology. There are different reasons for this, the primary one being the lack of certainty behind which directions will be successful (due to data quality and similar issues). Thus, what often happens in organizations is <em>pilotitis</em>&nbsp;- the disease of launching MVP after MVP without tangible progress and commitment.</p> <p>There is a method to address this issue while still alleviating the uncertainty behind planning MVPs - the Shotgun MVP. As a first step, several MVP initiatives are launched simultaneously (staffed to the bare minimum needed). Thus, all possible approaches are covered. This process continues for several sprints until a clear frontrunner becomes apparent - based on a &quot;success&quot; metric. There is flexibility in defining this metric, and possible examples include performance metrics (i.e., model accuracy) and solution complexity (such as the workforce needed to complete further development iterations). After this MVP (MVP II in our case) is selected, resources are committed fully to it for the following sprints while keeping the other options as backup plans or possible enhancements for downstream work.</p> <p>This simple procedure is not easy to perform and requires careful and restrained execution but can provide the shortest way to delivering a successful ML product.</p>

opencc-by-4.0Dec 2020View details →
zenodo32/100

Video of MVP Final version - OD and occupancy prediction for Bilbobus

<p>The video shows the final version of the solutions Transport Analytics and Occupancy API, deployed by Citio for the Bilbobus transport network, in the context of the REACH project.&nbsp;</p>

opencc-by-4.0Sep 2023View details →
ClinicalTrials.gov32/100

Oral Dydrogesterone (OD) Versus Micronized Vaginal Progesterone (MVP) for Luteal Phase Support (LPS) in IVF/ICSI

ClinicalTrials.gov study NCT03677336. IPD Sharing: UNDECIDED. Countries: 1. Publications: 1.

restrictedIPD-UNDECIDEDFeb 2026View details →
ClinicalTrials.gov32/100

Modifiable Variables in Parkinsonism (MVP)

ClinicalTrials.gov study NCT02194816. IPD Sharing: Not stated. Countries: 1. Publications: 2.

restrictedIPD-UNDECIDEDFeb 2026View details →
zenodo28/100

Respostas questionário MVP

<p>Este anexo cont&eacute;m os dados coletados por meio de um question&aacute;rio aplicado em startups, como parte do estudo sobre MVP (Minimum Viable Product). O objetivo da pesquisa foi analisar como startups lidam com o desenvolvimento, manuten&ccedil;&atilde;o e poss&iacute;veis substitui&ccedil;&otilde;es de seus MVPs ap&oacute;s a consolida&ccedil;&atilde;o no mercado. Os dados incluem respostas detalhadas sobre pr&aacute;ticas, desafios e decis&otilde;es relacionadas ao MVP, oferecendo uma vis&atilde;o aprofundada sobre a rela&ccedil;&atilde;o entre o produto m&iacute;nimo vi&aacute;vel e o ciclo de vida das startups.</p> <p><strong>Formato:</strong> Planilha Excel (.xlsx)</p> <p><strong>Conte&uacute;do:</strong></p> <ul> <li>Perguntas e respostas do question&aacute;rio aplicado</li> <li>Informa&ccedil;&otilde;es quantitativas e qualitativas fornecidas pelos participantes</li> <li>Dados anonimizados para preservar a confidencialidade dos respondentes</li> </ul> <p><strong>Uso:</strong> Os dados s&atilde;o &uacute;teis para pesquisadores, empreendedores e interessados no estudo de startups, desenvolvimento de produtos e inova&ccedil;&atilde;o tecnol&oacute;gica.</p> <p><strong>Palavras-chave:</strong> MVP, startups, desenvolvimento de produtos, inova&ccedil;&atilde;o, question&aacute;rio, pesquisa aplicada.</p>

opencc-by-4.0Nov 2024View details →
geo24/100

Transcriptome analysis on wild type and mvp mutant zebrafish ventricles at 7dpa by Next Generation Sequencing

GEO Series GSE157170. Danio rerio. 12 samples. Type: Expression profiling by high throughput sequencing.

openGEO-OpenSep 2020View details →
ClinicalTrials.gov24/100

Neuroliten MVP System Clinical Observation Study

ClinicalTrials.gov study NCT05520476. IPD Sharing: NO. Countries: 1. Publications: 0.

closedIPD-NOFeb 2026View details →
ClinicalTrials.gov24/100

Comparing Meniscal Repair Biologic Augmentation: Marrow Venting Procedure Versus PRP (MVP Trial)

ClinicalTrials.gov study NCT04775004. IPD Sharing: NO. Countries: 1. Publications: 0.

closedIPD-NOFeb 2026View details →
ClinicalTrials.gov24/100

Maveropepimut-S (MVP-S) and Low-Dose CPA in Patients With Platinum-Resistant Ovarian Cancer

ClinicalTrials.gov study NCT05243524. IPD Sharing: NO. Countries: 3. Publications: 0.

closedIPD-NOFeb 2026View details →
ClinicalTrials.gov24/100

Mitral Valve Prolapse (MVP) - France Study

ClinicalTrials.gov study NCT00799565. IPD Sharing: Not stated. Countries: 1. Publications: 0.

restrictedIPD-UNDECIDEDFeb 2026View details →
ClinicalTrials.gov24/100

Microvascular Plug (MVP) for the Treatment of Pulmonary ArterioVenous Malformations (PAVMs)

ClinicalTrials.gov study NCT04396041. IPD Sharing: Not stated. Countries: 1. Publications: 0.

restrictedIPD-UNDECIDEDFeb 2026View details →
ClinicalTrials.gov24/100

Exercise Capacity Evaluation in Patients With Non-rheumatic Mitral Valve Prolapse (MVP)

ClinicalTrials.gov study NCT02499419. IPD Sharing: Not stated. Countries: 1. Publications: 0.

restrictedIPD-UNDECIDEDFeb 2026View details →
ClinicalTrials.gov24/100

EarGenie MVP Performance Evaluation

ClinicalTrials.gov study NCT06406088. IPD Sharing: NO. Countries: 1. Publications: 0.

closedIPD-NOFeb 2026View details →
ClinicalTrials.gov24/100

MVP RCT: Mind and Voice Project Randomized Control Trial

ClinicalTrials.gov study NCT04018807. IPD Sharing: NO. Countries: 1. Publications: 0.

closedIPD-NOFeb 2026View details →
ClinicalTrials.gov24/100

AMBULATE VASCADE MVP Same Day Discharge Retrospective Registry

ClinicalTrials.gov study NCT04538781. IPD Sharing: NO. Countries: 1. Publications: 0.

closedIPD-NOFeb 2026View details →
ClinicalTrials.gov24/100

UVB-Induced MVP Release in Human Skin

ClinicalTrials.gov study NCT05734235. IPD Sharing: Not stated. Countries: 1. Publications: 0.

restrictedIPD-UNDECIDEDFeb 2026View details →

ScienceDex guides

Understand access before you commit

These curated guides explain access requirements, typical timelines, costs, and reuse considerations for widely used research datasets.

Compare curated datasets

Allen Brain Atlas

Allen Brain Atlas is an Allen Institute collection of brain map atlases, datasets, APIs, and analysis tools covering mouse, human, and non-human primate brain resources.

allen-brain-atlas
neuroscienceopenDocumentation, web resources, and API references are available online.
Last verified 2026-04-30Open record

Annotated Behaviour and Observability Dataset (ABODe)

ABODe is a University of Edinburgh DataShare dataset for behavior classification in group-housed mice using home-cage video, identities, bounding boxes, ground-plate positions, and annotator labels.

abode-home-cage
behavioral-neuroscienceopenThe DataShare record exposes download links for annotations, documentation, license text, and the zipped per-snippet data directory.
Last verified 2026-04-30Open record

DANDI Archive for NWB datasets

DANDI is a BRAIN Initiative archive for publishing and sharing neurophysiology data, including electrophysiology, optophysiology, and behavioral data packaged as NWB and related standards.

dandi-nwb
electrophysiologyopenPublished Dandiset metadata and archive endpoints are available through the production DANDI API.
Last verified 2026-04-30Open record

International Brain Laboratory public data

The International Brain Laboratory public data releases expose standardized mouse decision-making experiments, including Neuropixels recordings, widefield calcium imaging, behavior, and session metadata accessed through the ONE API.

ibl
behavioral-neuroscienceopenPublic sessions can be searched and loaded from the IBL public data server through ONE.
Last verified 2026-04-29Open record

OpenNeuro

OpenNeuro is a free, open platform for sharing neuroimaging datasets, with public search, dataset pages, and download paths for web, S3, DataLad, and the OpenNeuro CLI.

openneuro
neuroscienceopenPublished datasets are available on demand over the internet.
Last verified 2026-04-29Open record